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Abstract
The current study tests the hypothesis that multi-walled carbon nanotubes (MWCNT) with 
different surface chemistries exhibit different bioactivity profiles in vivo. In addition, the study 
examined the potential contribution of the NLRP3 inflammasome in MWCNT-induced lung 
pathology. Unmodified (BMWCNT) and MWCNT that were surface functionalised with -COOH 
(FMWCNT), were instilled into C57BL/6 mice. The mice were then examined for biomarkers of 
inflammation and injury, as well as examined histologically for development of pulmonary disease 
as a function of dose and time. Biomarkers for pulmonary inflammation included cytokines, 
mediators and the presence of inflammatory cells (IL-1β, IL-18, IL-33, cathepsin B and 
neutrophils) and markers of injury (albumin and lactate dehydrogenase). The results show that 
surface modification by the addition of the -COOH group to the MWCNT, significantly reduced 
the bioactivity and pathogenicity. The results of this study also suggest that in vivo pathogenicity 
of the BMWCNT and FMWCNT correlates with activation of the NLRP3 inflammasome in the 
lung.
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Nanotechnology is emerging as one of the world’s most promising new technologies. In 
fact, the field of nanotechnology is already a global multi-billion dollar investment market. 
Nanotechnology is currently at the forefront of scientific research and technological 
developments that have resulted in the manufacture of novel consumer products and 
numerous industrial applications (Musee et al. 2011). This vastly expanding area of 
nanotechnology offers new opportunities for making superior materials for use in industrial 
and biomedical applications (McAllister et al. 2002; Grassian et al. 2007). In fact, 
manufactured nanoparticles display physicochemical characteristics and impart unique 
applications within the commercial, medical and environmental sectors (Li et al. 2011a,b; 
Wang et al. 2010). To support the vast expansion of nanotechnology applications, a number 
of nanoparticles are being produced in large volumes. For example, carbon nanotubes 
(CNTs) are <100 nanometer diameter tubes of carbon, which are being developed and 
produced in mass quantities for a variety of applications. Since their discovery, many 
variations of CNTs have been developed, including variations in number of shells or tubes 
of carbon atoms. The two principal forms of CNT being utilised are the single-walled 
(SWCNT) and multi-walled (MWCNT) carbon nanotubes.
The applications of these CNTs include a variety of functions such as strengthening of 
composite materials, medical imaging, drug delivery, bone grafting, dental implants and as a 
key component in lithium batteries. In fact, CNTs exhibit excellent electrical, optical and 
chemical properties with a broad range of applications. Due to their wide range of 
applications, CNT production is estimated to reach into the millions of tons within the 
decade (Endo et al. 2008). However, even though production of CNTs are vastly increasing, 
the main problem with the majority of popular synthetic methods is that they produce 
samples yielding a mixture of various diameters and chiralities of nanotubes that are 
normally contaminated with metallic and amorphous impurities. Thus, functionalisation and 
post-synthesis chemical processing that can purify CNTs and also separate individual tubes 
according to diameter and chirality are proving to be viable routes to rational and predictable 
manipulation of the favourable electronic and mechanical properties of CNTs (Niyogi et al. 
2002; Tasis et al. 2003). Therefore, a suitable functionalisation via the physical or chemical 
attachment of functionalities onto the CNT surface, represents a strategy for not only 
improving the dispersion and solubility but for also allowing strong interfacial interactions 
to take place between the CNT and some other entities such as polymers, biomolecules or 
nanoparticles (Kim 2011). In addition, functionalisation and surface modification of CNTs 
with organic functional molecules extends their already broad applications. Therefore, the 
addition of organic coatings, such as -COOH terminated coatings, alters the charge, 
functionality and reactivity of the CNT.
Even though CNTs offer a wide variety of applications, the development of these engineered 
CNTs has unfortunately surpassed evaluation of their potential human health impacts. The 
potential adverse health effects associated with the inhalation of airborne nanoparticles are 
topics of ongoing scientific and public concern (Lippman et al. 2003; Wittmaack, 2007). 
Due to the physical and chemical durability and fibrous nature of the CNT, concern has been 
raised that some of the multi-walled variety of CNTs may exhibit potentially significant 
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health hazards similar to asbestos (Donaldson et al. 2006). Previous studies analysing the 
pulmonary toxicity of both SWCNT and MWCNT have shown that both types of CNT 
facilitate an increase in inflammation, fibrosis and granuloma formation (Lam et al. 2004; 
Shvedova et al. 2005; Porter et al. 2010; Porter et al. 2012). Therefore, previous studies have 
indicated that exposure to some CNTs may have adverse health impacts, which would in 
turn, limit or prevent the useful applications of CNT in the future. Therefore, continued 
evaluation of the potential toxicity of multi-walled CNTs is warranted.
One strategy that has been suggested to reduce the bioactivity of MWCNT is to alter their 
surface chemistry via addition of organic functional groups. Thus, in this study two different 
MWCNT were evaluated in vivo. The first had no surface modifications (i.e., as made) and 
was termed bare MWCNT (BMWCNT) and the second was modified by addition of 
carboxylic acid groups and was termed functionalised MWCNT (FMWCNT). Using these 
two MWCNT samples, the authors tested the hypothesis that MWCNT with different 
surface chemistries will exhibit different toxicity profiles in vivo. To test this hypothesis, 
mice were exposed to varying doses of BMWCNT or FMWCNT and pulmonary 
inflammation and pathological changes were determined. Histopathology studies to 
investigate the development of pulmonary disease were also conducted. In addition, to 
explore the hypothesis that in vivo inflammation and fibrosis could be facilitated by 
lysosomal leakage leading to inflammasome activation, the differences in bioactivity of 
these two MWCNT were correlated with their differential activation of the NLRP3 
inflammasome.
Material and methods
Purification and functionalisation of MWCNT
Typically, 300 mg of MWCNT (Nanostructured & Amorphous Materials, Inc., Houston, 
TX, USA) were added into 100 ml of hydrochloric acid (HCl) (con. 36.5%), in a 250 ml 
three-neck flask and then sonicated for 30 min. Subsequently, the mixture was then refluxed 
at 80–90°C for 4 h. Next, the suspension was centrifuged after it was naturally cooled down 
to room temperature. The black precipitates were collected, washed with deionised water 
and ethanol. Finally, it was subjected to centrifugation and decantation until the pH value 
reached 7.0. The resulting BMWCNT were dried in a vacuum oven at room temperature 
overnight, and then stored in a vial for use.
FMWCNT were prepared by the oxidation of the BMWCNT in HNO3 (con. 63%). Briefly, 
300 mg of BMWCNT were added into 100 ml of HNO3 in a three-neck flask. The mixture 
was then refluxed at about 110°C for 12 h. The black solution was then centrifuged to 
collect the FMWCNT precipitate. The FMWCNT was washed with deionised water to 
remove HNO3 until a neutral solution was obtained. The resulting FMWCNT was dried in a 
vacuum oven at room temperature for at least 24 h.
MWCNT diameter analysis
A diameter size analysis of both the bare and functionalised MWCNT samples was 
conducted to demonstrate that functionalisation only affected the surfaces of MWCNT. 
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Specifically, low resolution transmission electron microscopy (TEM) images were captured 
as described above. In order to compare the particle size distributions between the bare and 
the functionalised MWCNT samples, the width of a nanotube in each sample were measured 
using a JEOL 1220 TEM at a magnification of ×20K. Approximately 100 particles were 
examined from each filter sample. For the width/diameter determination, the entire size 
range was divided into approximately 10 successive size intervals and the number of 
particles (ΔN) in each interval was determined. It was necessary that the size group be 
contiguous and that they cover the entire size range so that no particles are left out.
Preparation of BMWCNT and FMWCNT suspensions
BMWCNT and FMWCNT were suspended in a biocompatible dispersion medium (DM) (a 
combination of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and mouse albumin in 
concentrations that mimic diluted alveolar lining fluid) previously described by the authors’ 
laboratory (Porter et al. 2008). Specifically, DM is Ca2+- and Mg2+-free phosphate buffered 
saline (PBS), pH 7.4, supplemented with 5.5 mM D-glucose, 0.6 mg/ml serum albumin and 
0.01 mg/ml DPPC. The DM was briefly sonicated (Branson Sonifer 450, 10W continuous 
output, 1 min) before use. MWCNT were then suspended in the DM to produce the desired 
concentration. The MWCNT suspensions were then briefly sonicated (Branson Sonifer 450, 
10W continuous output, 10 min) to promote dispersion of the MWCNT samples.
Animals
C57BL/6J male mice (7 weeks old) were purchased from Jackson Laboratories (Bar Harbor, 
Maine, USA). Animals were housed in an AAALAC-accredited, specific pathogen-free, 
environmentally controlled facility and allowed to acclimate at least 7 days prior to use. The 
mice were monitored to be free of endogenous viral pathogens, parasites, mycoplasms, 
Helicobacter and CAR Bacillus. Mice were kept in ventilated cages, which were provided 
HEPA (high-efficiency particulate air) filtered air, with Alpha-Dri virgin cellulose chips and 
hardwood Beta-chips for bedding. The animals were maintained on a Harlan Teklad 7913, 
6% fat, irradiated diet and tap water, both of which were provided ad libitum. All animal 
protocols were approved by the NIOSH/Morgantown Institutional Animal Care and Use 
Committee.
Mouse pharyngeal aspiration
Suspensions of BMWCNT and FMWCNT were prepared as described above. Mice were 
then exposed to 0, 2.5, 10 or 40 µg/mouse of BMWCNT or FMWCNT by pharyngeal 
aspiration as described by Rao et al. (2003). Briefly, the animals were anaesthetised with 
isoflurane and placed on a board in a near vertical position. The animal’s tongue was 
extended with lined forceps and 50 µL of the respective particle suspension was placed on 
the back of the tongue, which was held until the suspension was aspirated into the lungs. 
Following release of the tongue, the mouse was gently lifted off the board, placed on its side 
and monitored for recovery from anaesthesia. Control mice were administered an equal 
volume of DM.
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At 1, 7 and 56 days post-exposure, mice were weighed, a deep plane of anaesthesia was 
established with an intraperitoneal injection of sodium pentobarbital (>100 mg/kg), and the 
mice were euthanised by exsanguination. The trachea was cannulated with a blunted 22-
gauge needle, and whole lung lavage (WLL) was performed using cold sterile Ca2+- and 
Mg2+-free PBS at a volume of 0.6 ml for first lavage (kept separate) and 1 ml for subsequent 
lavages. Approximately 4 ml WLL fluid per mouse was pooled and collected in sterile 
centrifuge tubes. Pooled WLL cells were washed in PBS by centrifugation (600 × g, 10 min, 
4°C) and resuspended in PBS. First-fraction WLL aliquots with the cells removed, were 
frozen or kept on ice for later analysis.
Cell counts and differentials and first WLL fluid analyses
Total WLL cell counts were obtained using a Coulter Multisizer 3 (Coulter Electronics, 
Hialeah, FL, USA) and cytospin preparations of the WLL cells were made using a 
cytocentrifuge (Shandon Elliot Cytocentrifuge, London, UK). The cytospin preparations 
were stained with modified Wright-Giemsa stain and cell differentials were determined by 
light microscopy. Lactate dehydrogenase (LDH) activities and albumin concentrations of the 
first WWL fluid were measured to assess cytotoxicity and the integrity of the lung blood–
gas barrier, respectively. LDH activities and albumin concentrations were measured using a 
COBAS MIRA Plus chemical analyzer (Roche Diagnostic Systems Inc., Montclair, NJ, 
USA) as previously described (Porter et al. 2010).
First WLL fluid assays
The presence of inflammatory mediators associated with NLRP3 activation (IL-1β, IL-18 
and IL-33) in the first WLL fluid was measured 1 day post-exposure for the 40 µg/mouse 
dose level. The levels of the cytokines present were measured using commercially available 
ELISA kits (BioSource International Inc., Camarillo, CA, USA) as previously described 
(Hamilton et al. 2009).
To determine cathepsin B activity, the following assay components were mixed in a 96-well 
plate using PBS as diluent: first WLL fluid (50 µl), 2 µg Z-LR-AMC (fluorogenic Peptide 
Substrate, R&D systems, Minneapolis, MN, USA) ± 66 µM inhibitor (Z-Phe-Phe-FMK, 
MBL International, Woburn, MA, USA) in a total volume of 150 µl. The assay samples 
were incubated at 37°C for 1 h then fluorescence was measured using a plate reader at 380 
nm excitation and 460 nm emission. Cathepsin B-specific activity was calculated as follows: 
relative fluorescence units (RFU) from the cathepsin B activity (no inhibitor) minus with 
inhibitor.
Enhanced dark field microscopy
Mice (male, C57BL/6J, 7 weeks old) were dosed with 40 µg/mouse of the specific MWCNT 
suspensions following the same procedures outlined above. At 56 days post-exposure, mice 
were euthanised by an overdose of pentobarbital (>100 mg/kg body weight, i.p.) followed 
by transection of the abdominal aorta to provide exsanguinations. The lungs were rapidly 
removed and fixed by intratracheal perfusion with 1 cc of 10% neutral buffered formalin. 
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Lungs were then processed overnight in a tissue processor, and embedded in paraffin. 
Sections (5 µm thick) were collected on precleaned slides, deparaffinised and stained with 
sirius red before being cover slipped. Slides were imaged using a high signal-to-noise, dark 
field-based illumination on a CytoViva Olympus BX-41 microscope (CytoViva, Auburn, 
AL, USA) at 100× with oil immersion. Images of the lung tissue were captured with a Dage-
MTI digital camera (2048 × 2048, Dage, Michigan City, IN, USA).
Histopathology
Lung histopathology was performed as previously described (Hubbs et al. 2002). Briefly, 
mice were anaesthetised with an intraperitoneal injection of sodium pentobarbital (>100 
mg/kg) and the abdominal aorta was transected for exsanguination. Whole lungs were 
inflated with 1 ml of 10% neutral buffered formalin. All collected tissues were trimmed the 
same day, with sections of the right and left lung lobes and the tracheobronchial lymph node 
(TBL), if found, also trimmed. Tissues were processed overnight and embedded the 
following day in paraffin.
Lung sections (5 microns thick) were stained with H&E, picrosirius red and Masson’s 
trichrome. All histology sections were interpreted by a board-certified veterinary pathologist 
who was blind to the experimental conditions. Microscopic evaluation included assessments 
of cellular uptake of the MWCNT, inflammation and fibrosis in the lung as well as particle 
translocation to the TBL. Each histopathologic change was scored for distribution and for 
severity according to the following parameters: distribution (0 = none, 1 = focal, 2 = focally 
extensive, 3 = multifocal, 4 = multifocal and coalescent, 5 = diffuse) and severity scores (0 = 
none, 1 = minimal, 2 = mild, 3 = moderate, 4 = marked, 5 = severe) as previously described 
by Hubbs et al. (1997). A composite score for each change consisting of the sum of the 
distribution and severity scores were recorded.
Statistics
Statistical comparisons between doses for each nanoparticle type (BMWCNT or FMWCNT) 
at a specific post-exposure time were performed separately for each post-exposure time 
using analysis of variance (ANOVA) with post hoc t-tests for pair-wise comparison of dose 
groups. Similar analyses were performed to compare post-exposure time effect for each 
nanoparticle type. Since variance estimates were different across dose groups, the ANOVA 
models were estimated using an unequal variance model available from SAS PROC 
MIXED. All statistical tests were two tailed with significance level equal to 0.05.
Since the pathology data consisted of ordinal scores rather than comparisons between 
control and MWCNT-exposed mice at each time, comparisons across time for each exposure 
group were accomplished using two separate one-way non-parametric ANOVA. Exact tests 
were used because of the high number of tied values in the data. The non-parametric 
ANOVA was performed using SAS Proc NPAR1WAY with exact Kruskal–Wallis tests for 
multi-group comparisons and exact Wilcoxon tests for post hoc pair-wise comparisons. All 
statistical tests were two-tailed with significance defined as type I probability of less than 
5% (p < 0.05).
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The samples used in this in vivo study were taken from the same batch employed for a 
companion in vitro study and the detailed information on the MWCNT materials utilised can 
be found in the authors’ accompanying paper (Hamilton et al. 2012). However, a brief 
summary of the characterisation results is given here. The raw MWCNT received from the 
commercial source contained 2.2 wt% nickel (Ni) and 0.08 wt% iron (Fe). After purification 
treatment in HCl solution, the Ni content in the BMWCNT was reduced to 0.96 wt%, and 
the presence of Fe was not detected by inductively coupled plasma mass spectrometry (ICP-
MS). After nitric acid (HNO3) treatment of the BMWCNT, 0.07 wt% Ni remained in the 
FMWCNT and the Fe content remained lower than the limit of detection of ICP-MS. The 
purification treatment in HCl solution removed the amorphous carbon layer from the surface 
of the MWCNT sample, which was confirmed by thermogravimetric analysis (TGA). After 
oxidation treatment in the HNO3 solution, the -COOH group was covalently bound to the 
surface of MWCNT, producing the FMWCNT. This addition of the -COOH group was 
confirmed by the measurement of X-ray photoelectron spectroscopy (XPS). The band at 
1722 cm−1 in the Fourier-transform infrared (FTIR) spectrum further confirmed the 
presence of -COOH group. Lastly, the BMWCNT and FMWCNT samples were placed into 
the DM used for in vivo study, and the zeta potentials of each sample were obtained. The 
zeta potentials of BMWCNT and FMWCNT were −9.76 and −13.8 mV, respectively. The 
BMWCNT width had a count median diameter of 42 nm (geometric standard deviation 
(GSD) = 1.4). The FMWCNT width had a count median diameter of 44 nm (GSD = 1.4). 
Thus, the diameter analyses indicated no differences in diameter existing between the 
BMWCNT and FMWCNT samples. As previously mentioned, due to the fact that the CNTs 
are not rigid, the attempts to track single nanotubes from end to end were not successful. 
Therefore, it is very challenging to accurately measure the exact length of nanotubes.
Comparison of pulmonary inflammation and damage of BMWCNT and FMWCNT
At 1 day post-exposure, all doses of BMWCNT caused a significant increase in 
polymorphonuclear neutrophil (PMN) counts over control, while at 7 days post-exposure 
only the highest dose (40 µg/mouse) remained significantly elevated over the control (Figure 
1A). By contrast, at 1 day post-exposure, only the highest dose (40 µg/mouse) of FMWCNT 
caused a significant increase in PMN versus control. This inflammatory response decreased 
at 7 days post-exposure, but remained significantly greater than control (Figure 1B).
Albumin levels in the first fraction of WLL fluid were analysed to assess air/blood barrier 
injury after MWCNT exposures. Both BMWCNT and FMWCNT caused dose-dependent 
increases in albumin levels. At 1 and 7 days post-exposure, all doses of BMWCNT caused a 
significant increase in albumin levels over control (Figure 2A). For the FMWCNT, at 1 day 
post-exposure, all doses caused a significant increase in albumin levels over control. 
However, at 7 days post-exposure, only the 40 µg/mouse dose caused a significant increase 
in albumin levels over control (Figure 2B).
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LDH activities were measured to assess cytotoxicity after MWCNT exposure. Similar to the 
PMN influx and albumin data, both BMWCNT and FMWCNT caused a dose-dependent 
increase in LDH activities in the WLL fluid. At 1 and 7 days post-exposure, all doses of the 
BMWCNT caused a significant increase in LDH activity over control (Figure 3A). For the 
FMWCNT, at 1 day post-exposure, all doses caused a significant increase in LDH activity 
over control. However, at 7 days post-exposure only the intermediate and highest doses (10 
and 40 µg/mouse) of FMWCNT caused a significant increase in LDH activity over control 
(Figure 3B).
To compare the inflammatory response and lung pathology elicited by BMWCNT and 
FMWCNT, data for mice exposed to 40 µg/mouse were re-plotted for 1 and 7 days post-
exposure times. These analyses indicated that relative to FMWCNT-exposed mice, 
BMWCNT caused substantially greater influx of PMNs, that is, 2.5- and 6.1-fold at 1 day 
and 7 days post-exposure, respectively (Figure 4). Relative to FMWCNT-exposed mice, 
BMWCNT albumin concentrations were 1.4-fold higher at 1 day post-exposure, and 2.2-
fold higher at 7 days post-exposure (Figure 4B). Finally, relative to FMWCNT-exposed 
mice, BMWCNT LDH activities were 1.3-fold higher at 1 day post-exposure, and 1.4-fold 
higher at 7 days post-exposure (Figure 4C) relative to FMWCNT-exposed mice.
NLRP3 inflammasome activation
To determine if BMWCNT and FMWCNT cause phagolysosomal lysis (release of cathepsin 
B) and activation of the NLRP3 inflammasome, cathepsin B activities as well as IL-1β, 
IL-33 and IL-18 cytokine levels were measured in the first WLL fluid from mice 1 day after 
exposure to 40 µg/mouse doses. Cathepsin B activities for animals receiving FMWCNT and 
BMWCNT were significantly higher than control levels. When comparing the FMWCNT 
with BMWCNT, BMWCNT resulted in significantly higher (6.3-fold) levels of cathepsin B 
activity than FMWCNT (Figure 5A). IL-1 β levels for animals receiving FMWCNT were 
not significantly different than control levels of IL-1 β, but BMWCNT-exposed mice were 
significantly higher than controls and FMWCNT (Figure 5B). IL-18 levels of either the 
BMWCNT or FMWCNT exposure groups were significantly higher than control levels, 
with animals exposed to BMWCNT resulting in significantly higher (2-fold) levels of IL-18 
than FMWCNT (Figure 5C). IL-33 levels for animals exposed to BMWCNT, but not 
FMWCNT, were significantly higher than control levels (Figure 5D). Taken together, the 
data indicate that MWCNT caused phagolysosomal lysis and activation of the NLRP3 
inflammasome, which was greater in the BMWCNT compared with FMWCNT.
Enhanced dark field microscopy imaging
The enhanced dark field images taken using the CytoViva microscope at 56 days post-
exposure allowed for determination of where the MWCNT are found within the lung. The 
results of the CytoViva microscopy studies indicate that BMWCNT are observed generally 
diffuse within the interstitial tissue, but also in condensed areas of alveolar macrophages 
(AMs) which have significant amounts of BMWCNT (Figure 6A). This outcome is 
drastically different for mice exposed to FMWCNT. At 56 days post-exposure, the presence 
of FMWCNT within the interstitial tissue is sparse, and no AMs containing FMWCNT were 
observable (Figure 6B). Finally, comparison of BMWCNT- and FMWCNT-exposed mice 
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(Figure 6A and B) indicates that a greater amount of BMWCNT are present within the lung, 
suggesting BMWCNT are cleared less efficiently than the FMWCNT.
Histopathological analyses
The histopathological findings are presented in Table I. At 7 days post-exposure, the 
presence of phagocytosed foreign material was noted in all animals exposed to either 
BMWCNT or FMWCNT and was significantly different from DM-exposed vehicle controls. 
The severity of this finding was graded as minimal to mild, and for either MWCNT 
products, respectively. The degree of phagocytosis was greater in animals exposed to a dose 
of 40µg/mouse as compared with 2.5 µg/mouse. Occasionally, AMs that contained 
aggregated material formed small, several-cell clusters within alveolar lumen, which were 
associated with localised interstitial fibrosis. AM clusters were essentially limited to lungs 
that had higher distribution and severity scores for phagocytosed material. The prevalence 
and severity of phagocytosed foreign material were generally comparable for mice exposed 
to 40 µg/mouse of either BMWCNT or FMWCNT at 7 days post-exposure; however, among 
mice that received a 2.5 µg/mouse dose, at 7 days post-exposure, low prevalence of 
aggregated foreign material and foreign material within epithelial cells were only seen in 
mice exposed to BMWCNT.
Other histopathology findings in the lungs at 7 days post-exposure included: alveolitis (non-
macrophage leucocytic infiltrates within alveolar lumina), acute bronchiolitis (primarily 
neutrophilic leucocytic infiltrates within bronchiolar lumina) and interstitial fibrosis 
(thickening of alveolar septae with increased collagen formation). The severities of these 
diagnoses were uniformly minimal, and their prevalence tended to be only slightly higher in 
treated mice versus untreated controls. At the 40 µg/mouse dose, alveolitis and fibrosis for 
BMWCNT tended to exceed that for FMWCNT, consistent with the WLL inflammatory 
biomarkers.
TBL: 7 days post-exposure
The only clear treatment-related finding in the TBL was the presence of phagocytosed 
foreign material, which occurred in animals exposed to either BMWCNT or FMWCNT. The 
foreign material, which was virtually identical to foreign material in the lung, was present 
within the cytoplasm of macrophages that were scattered primarily throughout the 
paracortex and medulla. The severity of this finding was minimal in all affected TBL.
Lung: 56 days post-exposure
At 56 days post-exposure, the presence of phagocytised foreign material appeared 
qualitatively similar to the material observed at 7 days post-exposure. The prevalence of 
phagocytosed foreign material (including material within alveolar epithelial cells) in both 
types of BMWCNT and FMWCNT at both dose concentrations (2.5 and 40 µg/mouse) 
tended to be slightly lower in day 56 animals as compared with mice of the day 7 sacrifice.
Also, at 56 days post-exposure, interstitial fibrosis was observed nearly exclusively in mice 
treated with 40 µg/mouse of BMWCNT (Figure 7), and there was a moderate prevalence of 
alveolitis that was limited entirely to mice exposed to BMWCNT at 40 µg/mouse (Table I). 
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The prevalence of alveolitis and interstitial fibrosis in mice exposed to 40 µg/mouse 
BMWCNT was significantly greater than the prevalence in control or FMWCNT mice 
(Table I). These fibrosis data are consistent with and supported by the CytoViva dark field 
image analyses showing that the BMWCNT are more persistent than the FMWCNT within 
the interstitial tissue of the lung at 56 days post-exposure.
TBL: 56 days post-exposure
In mice sacrificed on day 56, the sole treatment-related finding in the TBL was the presence 
of phagocytosed foreign material, which occurred in animals exposed to 40 µg/mouse of 
either BMWCNT or FMWCNT (Table I). Mean severity scores for this finding were slightly 
higher for day 56 mice as compared with day 7 mice. Similar to day 7 mice, the generally 
low prevalence and severity of haemosiderin-laden macrophages in TBL subscapular 
sinuses of day 56 mice were comparable among control and treated animals.
Discussion
Over the last 20 years, CNT have received considerable attention from many researchers due 
to their interesting properties and broad applications. In addition to their outstanding 
mechanical characteristics, CNT exhibit excellent electrical and thermal properties. These 
superior properties provide exciting opportunities to produce advanced materials for new 
applications (Dresselhaus et al. 2001; Abuilaiwi et al. 2010). Because of the rapid growth in 
the manufacturing and use of CNT, concerns have been raised about their potential adverse 
effects on both human health and the environment. The present study specifically examined 
the potential pulmonary responses to MWCNT exposure and the effects of surface 
modification of the MWCNT, in particular the addition of carboxyl groups, to assess if 
surface carboxylation reduces the bioactivity of the nanomaterial in vivo. Mechanistically, 
the current study also evaluated if the in vivo bioactivity of MWCNT correlates with 
activation of the NLRP3 inflammasome (Figure 8).
Effect of surface modification on the bioactivity of MWCNT
Surface modification of MWCNT with functional moieties is a key step to extend their 
applications in biological and industrial areas. The surface functional groups can alter the 
surface charge and reactivity of the surface, and enhance the stability and dispersion of 
MWCNT. For example, functionalisation of MWCNT with the COOH moiety can change 
the MWCNT from a hydrophobic state to hydrophilic state, thus providing active sites for 
further conjugation. Furthermore, carboxylation of MWCNT can result in a less 
hydrophobic, more negatively charged particle, which may affect how cells interact with the 
MWCNT.
Therefore, the first hypothesis of this study was that surface modification, in particular the 
addition of carboxylic acid groups to the MWCNT surface, would reduce their bioactivity in 
vivo in a similar manner to what we observed in vitro (Hamilton et al. 2012). The current 
study results show that this surface modification did significantly reduce the bioactivity of 
the MWCNT. In fact, the inflammatory response elicited by the FMWCNT was 
approximately 2.5- and 6.1- fold lower than the BMWCNT response at both 1 and 7 days 
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post-exposure, respectively. The air–blood barrier injury induced by exposure to the 
BMWCNT (40 µg/mouse) was 1.4- and 2.2-fold greater than FMWCNT at 1 and 7 days 
post-exposure, respectively. LDH activity in lung lavage fluid elicited by the highest dose of 
the BMWCNT was 1.3- and 1.4-fold greater at 1 and 7 days post-exposure, respectively. 
These results indicate that modifying the surface of the MWCNT with the -COOH group did 
in fact lower the bioactivity of the MWCNT.
As previously mentioned, the addition of surface functional groups can enhance the 
dispersion of the MWCNT. Previous studies have reported that well-dispersed MWCNT 
were found to be more bioactive in the lung, causing more inflammation and fibrosis than 
the same dose of poorly dispersed MWCNT (Wang et al. 2010; Shvedova et al. 2008). 
Furthermore, in studies utilising spherical metal oxide nanoparticles, the authors have 
previously shown that the more dispersed the nanoparticle solution administered in vivo or 
in vitro, the greater degree of bioactivity of the nanoparticles (Sager et al. 2007; Sager et al. 
2008). These past studies established dispersion status as a critical factor in determining 
MWCNT and spherical nanoparticle bioactivity and fibrogenicity. However, in the current 
study, surface modification, not CNT dispersion status of the MWCNT was the primary 
driving force behind differential bioactivity and fibrogenicity in the lung. In order to focus 
on the effects of surface functionalisation, the current study was able to eliminate the 
variable of dispersion status by producing well-dispersed MWCNT samples. The results of 
the study shows that a well-dispersed FMWCNT is less bioactive in the lung, causing 
significantly less inflammation and fibrosis when compared with the same unmodified well-
dispersed BMWCNT. These results therefore indicate that surface modification with 
functionalisation promotes the “safety by design” concept in regards to MWCNT production 
and utilisation.
The results of the current study are consistent with the findings of other studies investigating 
the pulmonary toxicity of MWCNT. For example, Tabet et al. (2011) reported that coating 
MWCNT with polystyrene significantly lowered the pulmonary cytotoxicity and 
inflammation when compared with the untreated MWCNT. A study conducted by Kim et al. 
(2010) reported that the unmodified MWCNT caused significantly more inflammation in the 
lung than acid-treated MWCNT. Another recent study conducted by Wang et al. (2012) 
reported that MWCNT suspended in pluronic F108 possessed a higher degree of dispersion 
than the MWCNT suspended in bovine serum albumin (BSA). However, exposures to 
MWCNT suspended in the BSA were more fibrogenic and in vivo than exposures to the 
same concentration of pluronic F108 suspended MWCNT. The Wang et al. study concluded 
that pluronic F108 coated the MWCNT in a manner that they were unable to facilitate 
cellular events (e.g., phagolysosomal disruption) necessary to induce pathogenesis of 
pulmonary fibrosis. Taken together, these results demonstrate that coating the MWCNT 
surface with substances such polystyrene or pluronic F108 or functionalising the MWCNT 
surface, without affecting their intrinsic structure, may constitute a useful strategy for 
decreasing MWCNT toxicity. However, it is highly probable that the effect of coating or 
functionalising the surface of MWCNT on toxicological outcomes will be dependent on 
coating and/or functional group specific. Therefore, the degree to which a specific coating or 
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functional group may decrease MWCNT toxicity should be assessed on a case-by-case 
basis.
Role of the NLRP3 inflammasome activation on MWCNT bioactivity
Based on the findings discussed above, the overall conclusion of the current study was that 
BMWCNT were more bioactive than the FMWCNT. Thus, the authors wanted to further 
investigate the basis for this difference in bioactivity. Previous data from the authors’ 
laboratory have shown that titanium dioxide (TiO2) nanobelts were highly toxic to AMs in 
vitro, but TiO2 nanospheres were not (Hamilton et al. 2009). This study also provided 
evidence that this differential toxicity was related to activation of the NLRP3 
inflammasome. Furthermore, an in vivo study conducted by Yazdi et al. (2010) concluded 
that mice subjected to inhalation exposure of nano-TiO2 developed lung inflammation 
catalysed by the activation of the NLRP3 inflammasome, leading to IL-1β release. To 
support their conclusion of the NLRP3 inflammasome-induced inflammatory response, 
Yazdi et al. showed that the inflammatory response to the same nano-TiO2 exposure was 
decreased in IL-1β deficient mice. Thus, these findings propelled us to investigate if the 
mechanism responsible for the difference in bioactivity of BMWCT versus FMWCNT 
might also be differential activation of the NLRP3 inflammasome.
Current evidence suggests that toxic nanoparticles could potentially increase 
phagolysosomal membrane permeability and release of cathepsin B causing activation of the 
NLRP3 inflammasome, which induces the release of pro-inflammatory cytokines (IL-1β and 
IL-18) from AMs and most likely IL-33 from epithelial cells (Figure 8) (Beamer et al. 
2012). This family of cytokines has been shown to significantly contribute to the acute 
inflammatory response, for example, PMN infiltration (Hamilton et al. 2009) as well as 
fibrosis (Wang et al. 2012) both in vitro and in vivo. In fact, a recent study by Beamer et al. 
(2012) has shown that MWCNT exposure in C57BL/6 mice resulted in elevated levels of 
IL-33 in the lavage fluid. The findings of Beamer et al. (2012) also support the findings of 
the current study, which suggests that activation of the NLRP3 inflammasome induces the 
release of IL-33 from epithelial cells as a result of MWCNT exposure, in turn promoting the 
acute inflammatory response.
When inhaled particles, including MWCNT, deposit in the distal airways and alveoli, they 
are engulfed by AMs. AMs are present in the alveoli and on the surface of distal airways, 
and these pneumocytes are capable of phagocytising particles (Bals et al. 1999). During the 
phagocytosis process, the MWCNT are taken up into the macrophage’s phagolysosomes. 
This uptake into the phagolysosome of specific bioactive particles catalyses damage, 
phagolysosome leakage and cathepsin B release. This initial release of cathepsin B initiates 
the activation of the NLRP3 inflammasome, which cleaves the inactive pro forms of IL-1β, 
IL-18 and IL-33 to active forms of these cytokines. These cytokines are secreted into the 
alveolar lining fluid of the lung and in turn synergistically work to promote inflammation 
and fibrosis in the lung (Cassel et al. 2009).
In the present study, cathepsin B activity and IL-1β, IL-18 and IL-33 levels in the WLL fluid 
were monitored 1 day after exposure to 40 µg/mouse of BWMCT and FMWCNT. The 
results of the current study support the NLRP3 inflammasome activation hypothesis. 
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Specifically, cathepsin B activities for animals receiving BMWCNT and FMWCNT were 
significantly higher than control levels. However, when comparing BMWCNT with 
FMWCNT, the BMWCT caused significantly higher (6.3-fold greater) levels of cathepsin B 
activity than FMWCNT. Furthermore, the BMWCNT-exposed mice had significantly higher 
levels of IL-1β, IL-18 and IL-33 than FMWCNT. These findings are consistent with results 
from the in vitro studies (Hamilton et al. 2012) supporting the notion that in vitro studies of 
NLRP3 inflammasome activation could be used to predict in vivo outcomes.
Therefore, it is evident from the findings of the current study that NLRP3 inflammasome 
activation is potentially the driving force behind both the inflammatory and fibrogenic 
response of MWCNT exposure. However, it is important to note that functionalisation of the 
MWCNT surface downregulates activation of the NLRP3 pathway, significantly lessening 
the degree of inflammation and fibrosis in response to MWCNT exposure. More 
specifically, when comparing bare-unmodified MWCNT (BMWCNT) to surface modified 
(FMWCNT), it was found that the BMWCNT were pathogenically more bioactive in the 
lung, causing a more robust inflammatory and fibrotic response than FMWCNT. Not only 
did the BMWCNT cause a more acute pulmonary response in the lung (as indicated by PMN 
influx and greater LDH activity and albumin levels in BAL samples), the BMWCNT were 
also more fibrotic at 56 days post-exposure.
In conclusion, this current study suggests that the NLRP3 inflammasome is activated in vivo, 
after pulmonary exposure to MWCNT, and the extent of the activation was decreased by 
addition of -COOH on the surface of BMWCNT. The findings support the notion that the 
NLRP3 inflammasome plays a crucial role in the pathogenic response to MWCNT. In fact, 
data from the present study support a relationship between the extent of NLRP3 
inflammasome activation by BMWCNT or FMWCNT and the degree of pulmonary 
inflammation and fibrosis.
The results confirm that modification of the surface chemistry of the MWCNT with COOH- 
groups decreased their bioactivity. Specifically, the BMWCNT were more bioactive, 
causing more inflammation, lung pathology and fibrosis than the FMWCNT. This difference 
in bioactivity also correlated with the activation of the NLRP3 inflammasome. Furthermore, 
evidence provided from this study indicates that activation of the NLRP3 inflammasome is a 
good predictor of lung pathogenesis. In conjunction with the findings of the current study, 
many recent therapeutic goals to treat chronic inflammation in the lung have focused on 
interrupting or blocking the NLRP3 inflammasome pathway (Arend et al. 2008). It would be 
interesting to determine if this relationship holds true for other classes of engineered 
nanoparticles as well. These results certainly hold promise for “safety by design” efforts to 
improve occupational and environmental safety.
The present study is a part of a larger program with the goal of establishing what 
physicochemical properties of nanomaterials influence their pathogenicity. In turn, 
identifying important physicochemical properties contributing to nanoparticle pathogenicity 
could lead to the development of predictive model(s) of nanoparticle bioactivity. In the 
future, such information may allow material scientists to incorporate a “safety by design” 
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philosophy into the development of new nanoparticle-based technologies, which will use 
nanomaterials that pose lower risks to human health.
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Comparison of inflammation induced by pharyngeal aspiration exposure to 0, 2.5, 10 and 40 
µg/mouse of BMWCNT (A) and FMWCNT (B) at 1 and 7 days post-exposure. WLL PMNs 
were used as a marker of pulmonary inflammation. Values are given as means ± SE (n = 8). 
An asterisk (*) indicates that PMN influx for that group were significantly higher than 
control (p < 0.05).
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Comparison of air/blood barrier injury induced by pharyngeal aspiration exposure to 0, 2.5, 
10 and 40 µg/mouse of BMWCNT (A) or FMWCNT (B) at 1 and 7 days post-exposure. 
WLL fluid albumin concentrations were used as a marker of the air/blood barrier. Values are 
given as means ± SE (n = 8). An asterisk (*) indicates that albumin levels for that group 
were significantly higher than control (p < 0.05).
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Comparison of cytotoxicity induced by pharyngeal aspiration exposure to 0, 2.5, 10 and 40 
µg/mouse of BMWCNT (A) or FMWCNT (B) at 1 and 7 days post-exposure. WLL fluid 
LDH activities were used as a marker of cytotoxicity. Values are given as means ± SE (n = 
8). An asterisk (*) indicates that LDH activity for that group was significantly higher than 
control (p < 0.05).
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Comparison of inflammation (A), air/blood barrier injury (B) and cytotoxicity (C) induced 
by pharyngeal aspiration exposure to 40 µg/mouse of BMWCNT or FMWCNT at 1 and 7 
days post-exposure. Values are given as means ± SE (n = 8). An asterisk (*) indicates that 
levels for that group were significantly higher than control (p < 0.05). A (+) indicates that 
BMWCNT elicited levels that were significantly higher than FMWCNT (p < 0.05).
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Differential activation of the NLRP3 inflammasome by BMWCNT and FMWCNT. Mice 
were exposed by pharyngeal aspiration to 0 or 40 µg/mouse of either BMWCNT or 
FMWCNT and first WLL fluid was isolated at 1 day post-exposure. Cathepsin B activities 
(A) and concentrations of IL-1β (B), IL-18 (C) and IL-33 (D) were determined as described 
in the section “Materials and Methods”. Values are means ± SE (n = 8). An asterisk (*) 
indicates significant increase vs. control (p < 0.05). A (+) indicates that BMWCNT was 
significantly greater than FMWCNT (p < 0.05).
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Enhanced dark field imaging of BMWCNT (A) and FMWCNT (B) in mouse lungs at 56 
days post-exposure. Arrows indicate presence of MWCNT.
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Photomicrograph from the lung of a mouse 56 days after a single aspiration exposure to 
BMWCNT. Mild alveolar septal fibrosis is in the wall of an alveolar duct and is associated 
with interstitial BMWCNT (solid arrow). Macrophages contain phagocytised BMWCNT 
(dashed arrows). The nucleus in one of the macrophages is undergoing karyolysis, which 
suggests cytotoxicity. Sirius red stain; bar = 10 µm.
Sager et al. Page 23














Schematic of the NLRP3 inflammasome. In this study, the authors propose that the 
MWCNT being tested will act as danger signals to AMs, initiating an inflammatory cascade 
mediated through the NLRP3 inflammasome. In this schematic representation, MWCNT 
disrupt phagolysosomes, releasing cathepsin B and activating the NLRP3 inflammasome. 
Once activated, the NLRP3 inflammasome cleaves the proinflammatory mediators IL-1β 
and IL-18, which are subsequently released to initiate the inflammatory cascade.
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